JP2017008001A5 - - Google Patents

Download PDF

Info

Publication number: JP2017008001A5
Authority: JP; Japan
Prior art keywords: composition according; protective composition; retinal protective; vitamin; retinal
Prior art date: 2015-06-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2015127861A

Other languages

English (en)

Japanese (ja)

Other versions

JP2017008001A (ja

JP6646368B2 (ja

Filing date

2015-06-25

Publication date

2019-03-14

2015-06-25 Application filed filed Critical

2015-06-25 Priority to JP2015127861A priority Critical patent/JP6646368B2/ja

2015-06-25 Priority claimed from JP2015127861A external-priority patent/JP6646368B2/ja

2017-01-12 Publication of JP2017008001A publication Critical patent/JP2017008001A/ja

2019-03-14 Publication of JP2017008001A5 publication Critical patent/JP2017008001A5/ja

2020-02-14 Application granted granted Critical

2020-02-14 Publication of JP6646368B2 publication Critical patent/JP6646368B2/ja

Status Active legal-status Critical Current

2035-06-25 Anticipated expiration legal-status Critical

Links

230000001681 protective effect Effects 0.000 claims 7
230000002207 retinal effect Effects 0.000 claims 7
239000000203 mixture Substances 0.000 claims 6
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
239000004480 active ingredient Substances 0.000 claims 2
LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims 2
235000012680 lutein Nutrition 0.000 claims 2
229960005375 lutein Drugs 0.000 claims 2
KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims 2
ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims 2
239000001656 lutein Substances 0.000 claims 2
KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims 2
FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims 1
239000004475 Arginine Substances 0.000 claims 1
PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
235000013162 Cocos nucifera Nutrition 0.000 claims 1
244000060011 Cocos nucifera Species 0.000 claims 1
241000196324 Embryophyta Species 0.000 claims 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims 1
CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims 1
240000007594 Oryza sativa Species 0.000 claims 1
235000007164 Oryza sativa Nutrition 0.000 claims 1
235000010575 Pueraria lobata Nutrition 0.000 claims 1
244000046146 Pueraria lobata Species 0.000 claims 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
239000004473 Threonine Substances 0.000 claims 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
229930003451 Vitamin B1 Natural products 0.000 claims 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
229930003448 Vitamin K Natural products 0.000 claims 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
150000001413 amino acids Chemical class 0.000 claims 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
235000020958 biotin Nutrition 0.000 claims 1
239000011616 biotin Substances 0.000 claims 1
229960002685 biotin Drugs 0.000 claims 1
229910052791 calcium Inorganic materials 0.000 claims 1
239000011575 calcium Substances 0.000 claims 1
229960005069 calcium Drugs 0.000 claims 1
235000001465 calcium Nutrition 0.000 claims 1
239000002775 capsule Substances 0.000 claims 1
239000003795 chemical substances by application Substances 0.000 claims 1
229940074393 chlorogenic acid Drugs 0.000 claims 1
CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims 1
FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims 1
235000001368 chlorogenic acid Nutrition 0.000 claims 1
229910052804 chromium Inorganic materials 0.000 claims 1
239000011651 chromium Substances 0.000 claims 1
BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims 1
229940074391 gallic acid Drugs 0.000 claims 1
235000004515 gallic acid Nutrition 0.000 claims 1
239000008187 granular material Substances 0.000 claims 1
229910052742 iron Inorganic materials 0.000 claims 1
239000007788 liquid Substances 0.000 claims 1
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
239000000463 material Substances 0.000 claims 1
229910052750 molybdenum Inorganic materials 0.000 claims 1
239000011733 molybdenum Substances 0.000 claims 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims 1
150000008442 polyphenolic compounds Chemical class 0.000 claims 1
235000013824 polyphenols Nutrition 0.000 claims 1
239000000843 powder Substances 0.000 claims 1
235000009566 rice Nutrition 0.000 claims 1
239000003826 tablet Substances 0.000 claims 1
229960003495 thiamine Drugs 0.000 claims 1
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
235000010374 vitamin B1 Nutrition 0.000 claims 1
239000011691 vitamin B1 Substances 0.000 claims 1
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims 1
235000005282 vitamin D3 Nutrition 0.000 claims 1
239000011647 vitamin D3 Substances 0.000 claims 1
235000019168 vitamin K Nutrition 0.000 claims 1
239000011712 vitamin K Substances 0.000 claims 1
150000003721 vitamin K derivatives Chemical class 0.000 claims 1
229940021056 vitamin d3 Drugs 0.000 claims 1
229940046010 vitamin k Drugs 0.000 claims 1
239000011701 zinc Substances 0.000 claims 1
229910052725 zinc Inorganic materials 0.000 claims 1
235000016804 zinc Nutrition 0.000 claims 1

JP2015127861A 2015-06-25 2015-06-25 網膜保護組成物 Active JP6646368B2 (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP2015127861A JP6646368B2 (ja)	2015-06-25	2015-06-25	網膜保護組成物

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2015127861A JP6646368B2 (ja)	2015-06-25	2015-06-25	網膜保護組成物

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2019129277A Division JP6736137B2 (ja)	2019-07-11	2019-07-11	網膜保護組成物

Publications (3)

Publication Number	Publication Date
JP2017008001A JP2017008001A (ja)	2017-01-12
JP2017008001A5 true JP2017008001A5 (fr)	2019-03-14
JP6646368B2 JP6646368B2 (ja)	2020-02-14

Family

ID=57760779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2015127861A Active JP6646368B2 (ja)	2015-06-25	2015-06-25	網膜保護組成物

Country Status (1)

Country	Link
JP (1)	JP6646368B2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2019019072A (ja) *	2017-07-14	2019-02-07	寿スピリッツ株式会社	網膜保護剤の製造方法および網膜保護剤
JP2021158985A (ja) *	2020-03-31	2021-10-11	株式会社東洋新薬	経口組成物
JP7231232B2 (ja) *	2020-03-31	2023-03-01	株式会社東洋新薬	経口組成物
CN111440767B (zh) *	2020-04-24	2023-07-21	尚禾粒线体生物科技(深圳)有限公司	一种线粒体保护剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2882894B1 (fr) *	2005-03-11	2009-04-03	Larena Sa	Composition alimentaire suppletive
US7829126B2 (en) *	2005-10-26	2010-11-09	Abbott Laboratories	Infant formulas containing docosahexaenoic acid and lutein
RU2315612C1 (ru) *	2006-08-29	2008-01-27	Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод"	Средство для лечения заболеваний глаз
WO2010074940A1 (fr) *	2008-12-23	2010-07-01	Alcon Research, Ltd.	Compositions et compléments nutritionnels améliorant la santé oculaire et réduisant la réponse inflammatoire de l'oeil

2015
- 2015-06-25 JP JP2015127861A patent/JP6646368B2/ja active Active

Publication	Publication Date	Title
PH12018500212A1 (en)	2018-08-13	1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
WO2016064082A3 (fr)	2016-06-09	Nouveau dérivé aminoalkyle benzothiazépine et son utilisation
MX2017017090A (es)	2018-12-11	Compuestos derivados de sulfamida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6, y la composicion farmaceutica que comprende los mismos.
WO2013066839A3 (fr)	2015-06-25	Composés et procédés
WO2013066835A3 (fr)	2015-05-21	Composés et procédés
MY183536A (en)	2021-02-25	Pharmaceutical compositions comprising azd9291
EP4327880A3 (fr)	2024-05-22	Forme à l'état solide de succinate de ribociclib
MY193740A (en)	2022-10-27	"substituted 2,4 diamino-quinoline as new anticancer agents"
JP2017014155A5 (fr)	2019-03-22
WO2016046260A8 (fr)	2017-04-13	Composés de 1-alkyl-6-oxo-1,6-dihydropyridin-3-yle et leur utilisation comme modulateurs sgrm
HRP20220683T1 (hr)	2022-07-08	Liječenje parkinsonove bolesti
EP4653537A3 (fr)	2026-01-07	Rhodopsin-gentherapie zur regeneration des sehvermögens oder zur verhinderung der abnahme des sehvermögens
JP2017008001A5 (fr)	2019-03-14
WO2015001541A3 (fr)	2015-11-26	Composition de film pharmaceutique
EP3248603A4 (fr)	2017-12-27	Composition pharmaceutique destinée à la prévention, au traitement ou au ralentissement de la maladie d'alzheimer ou de la démence contenant un agent de type récepteur couplé à une protéine g 19 comme principe actif
EA202191683A1 (ru)	2021-09-01	Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
WO2016006974A3 (fr)	2016-07-21	Nouveaux dérivés triazolopyrimidinone ou triazolopyridinone et leur utilisation
WO2016006975A3 (fr)	2016-07-21	Nouveaux dérivés imidazotriazinone ou imidazopyrazinone et leur utilisation
JP2017012144A5 (fr)	2019-03-14
JP2017014164A5 (fr)	2019-03-14
JP2016210757A5 (fr)	2019-03-14
LT4081502T (lt)	2025-04-10	Ketoprofeno kokristalas ir jo gamybos būdas, jį apimančios farmacinės kompozicijos ir jų panaudojimo būdai
WO2016197042A8 (fr)	2017-03-30	Formulations à libération modifiée ou ciblée de linaclotide
WO2016072392A8 (fr)	2017-03-30	Agent pour favoriser la production de protéine tau, et médicament thérapeutique ou prophylactique et composition de produit alimentaire thérapeutique ou prophylactique pour une maladie causée par une carence en protéine tau
WO2015160249A3 (fr)	2015-12-10	Utilisation d'énoximone pour le traitement d'affections topiques associées au système immunitaire, dans une composition pharmaceutique ainsi que dans une préparation pharmaceutique